Researchers sceptical about J&J jab’s ability to guard against Delta
They say it produced lower levels of antibodies against the strain compared with others, but J&J disputes this
21 July 2021 - 19:33
Johnson & Johnson’s (J&J) single-dose Covid-19 vaccine produced relatively low levels of antibodies against the Delta variant in a study, raising questions about how well the shot will hold up against the strain that accounts for the vast majority of new cases around the world...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
This article is free to read if you sign up or sign in.
If you have already registered or subscribed, please sign in to continue.
Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.